{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:56:56Z","timestamp":1781636216258,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,16]]},"DOI":"10.7759\/cureus.110981","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:40:57Z","timestamp":1781635257000},"source":"Crossref","is-referenced-by-count":0,"title":["Silent Phaeochromocytoma in a Young Normotensive Woman"],"prefix":"10.7759","author":[{"given":"Ashakumari","family":"Badiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Siew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Al-Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline","volume":"99","author":"Lenders JW","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, et al.. Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014, 99:1915-42. 10.1210\/jc.2014-1498","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0483","article-title":"Life-threatening events in patients with pheochromocytoma","volume":"173","author":"Riester A","year":"2015","unstructured":"Riester A, Weismann D, Quinkler M, et al.. Life-threatening events in patients with pheochromocytoma. Eur J Endocrinol. 2015, 173:757-64. 10.1530\/EJE-15-0483","journal-title":"Eur J Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0321","article-title":"Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center","volume":"7","author":"Falhammar H","year":"2018","unstructured":"Falhammar H, Kjellman M, Calissendorff J. Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center. Endocr Connect. 2018, 7:186-92. 10.1530\/EC-17-0321","journal-title":"Endocr Connect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad401","article-title":"Pheochromocytomas most commonly present as adrenal incidentalomas: a large tertiary center experience","volume":"109","author":"Aggarwal S","year":"2023","unstructured":"Aggarwal S, Prete A, Chortis V, et al.. Pheochromocytomas most commonly present as adrenal incidentalomas: a large tertiary center experience. J Clin Endocrinol Metab. 2023, 109:e389-96. 10.1210\/clinem\/dgad401","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00019616-199903000-00002","article-title":"Adrenal incidentaloma: an important component of the clinical presentation spectrum of benign sporadic adrenal pheochromocytoma","volume":"9","author":"Kudva YC","year":"1999","unstructured":"Kudva YC, Young WF, Thompson GB, Grant CS, Van Heerden JA. Adrenal incidentaloma: an important component of the clinical presentation spectrum of benign sporadic adrenal pheochromocytoma. Endocrinologist. 1999, 9:77-80. 10.1097\/00019616-199903000-00002","journal-title":"Endocrinologist"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht M","year":"2023","unstructured":"Fassnacht M, Tsagarakis S, Terzolo M, et al.. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2023, 189:G1-G42. 10.1093\/ejendo\/lvad066","journal-title":"Eur J Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf154","article-title":"Postoperative outcomes in normotensive and hypertensive pheochromocytomas: an international study","volume":"110","author":"Araujo-Castro M","year":"2025","unstructured":"Araujo-Castro M, Herrera A, Wang Y, et al.. Postoperative outcomes in normotensive and hypertensive pheochromocytomas: an international study. J Clin Endocrinol Metab. 2025, 110:e3719-29. 10.1210\/clinem\/dgaf154","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-100911","article-title":"Clinical and pathological characteristics of hypertensive and normotensive adrenal pheochromocytomas","volume":"124","author":"Lu Y","year":"2016","unstructured":"Lu Y, Li P, Gan W, et al.. Clinical and pathological characteristics of hypertensive and normotensive adrenal pheochromocytomas. Exp Clin Endocrinol Diabetes. 2016, 124:372-9. 10.1055\/s-0042-100911","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2998","article-title":"Per-operative hemodynamic instability in normotensive patients with incidentally discovered pheochromocytomas","volume":"100","author":"Lafont M","year":"2015","unstructured":"Lafont M, Fagour C, Haissaguerre M, Darancette G, Wagner T, Corcuff JB, Tabarin A. Per-operative hemodynamic instability in normotensive patients with incidentally discovered pheochromocytomas. J Clin Endocrinol Metab. 2015, 100:417-21. 10.1210\/jc.2014-2998","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.11348","article-title":"Meta-analysis of \u03b1-blockade versus no blockade before adrenalectomy for phaeochromocytoma","volume":"107","author":"Schimmack S","year":"2020","unstructured":"Schimmack S, Kaiser J, Probst P, Kalkum E, Diener MK, Strobel O. Meta-analysis of \u03b1-blockade versus no blockade before adrenalectomy for phaeochromocytoma. Br J Surg. 2020, 107:e102-8. 10.1002\/bjs.11348","journal-title":"Br J Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000000390","article-title":"Preoperative \u03b1-blockade versus no blockade for pheochromocytoma-paraganglioma patients undergoing surgery: a systematic review and updated meta-analysis","volume":"109","author":"Wang J","year":"2023","unstructured":"Wang J, Liu Q, Jiang S, Zhang J, He J, Li Y, Wang D. Preoperative \u03b1-blockade versus no blockade for pheochromocytoma-paraganglioma patients undergoing surgery: a systematic review and updated meta-analysis. Int J Surg. 2023, 109:1470-80. 10.1097\/JS9.0000000000000390","journal-title":"Int J Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson LD","year":"2002","unstructured":"Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol. 2002, 26:551-66. 10.1097\/00000478-200205000-00002","journal-title":"Am J Surg Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318190d12e","article-title":"Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score","volume":"33","author":"Wu D","year":"2009","unstructured":"Wu D, Tischler AS, Lloyd RV, DeLellis RA, de Krijger R, van Nederveen F, Nos\u00e9 V. Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score. Am J Surg Pathol. 2009, 33:599-608. 10.1097\/PAS.0b013e318190d12e","journal-title":"Am J Surg Pathol"},{"key":"ref14","article-title":"The systems of metastatic potential prediction in pheochromocytoma and paraganglioma","volume":"10","author":"Wang Y","year":"2020","unstructured":"Wang Y, Li M, Deng H, Pang Y, Liu L, Guan X. The systems of metastatic potential prediction in pheochromocytoma and paraganglioma. Am J Cancer Res. 2020, 10:769-80.","journal-title":"Am J Cancer Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/494575-silent-phaeochromocytoma-in-a-young-normotensive-woman","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:40:58Z","timestamp":1781635258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/494575-silent-phaeochromocytoma-in-a-young-normotensive-woman"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.110981","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}